CN102805830A - Traditional Chinese medicine composite for treating acne - Google Patents
Traditional Chinese medicine composite for treating acne Download PDFInfo
- Publication number
- CN102805830A CN102805830A CN 201110156586 CN201110156586A CN102805830A CN 102805830 A CN102805830 A CN 102805830A CN 201110156586 CN201110156586 CN 201110156586 CN 201110156586 A CN201110156586 A CN 201110156586A CN 102805830 A CN102805830 A CN 102805830A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- acne
- chinese medicine
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composite for treating acne, which belongs to the field of traditional Chinese medicine for treating dermatosis. The composite is composited by the following traditional Chinese medicinal materials: 10-20 parts of skullcap, 10-20 parts of cortex moutan, 5-15 parts of herba schizonepetae, 5-15 parts of radix angelicae, 10-20 parts of radix rehmanniae, 5-15 parts of platycodon roots, 10-25 parts of radix sophorae flavescentis, 15-25 parts of glabrous greenbrier rhizome and 10-20 parts of chrysanthemum. The invention provides the traditional Chinese medicine composite that is safe, non-toxic, and convenient to use and can treat the acne.
Description
Technical field
The invention belongs to treatment by Chinese herbs dermatosis technical field, relate in particular to a kind of Chinese medicine composition of treating acne.
Background technology
Acne is commonly called as " comedo ", has another name called " acne ", " whelk ", " skin sore " etc., good usually sending out in face, cervical region, chest and back, shoulder and upper arm.It is a kind of chronic inflammatory disease dermatoses of pilosebaceous unit, and clinical serves as main performance with hoary hair's acne, blackhead, inflammatory pimple, pustule, tuberosity, cyst etc.This disease adolescence sees more, but also not exclusively receives the restriction of age level, and from child to adult, the people of nearly all age bracket can fall ill.Acne is to occur in pilosebaceous chronic dermatosis, and the factor of generation is varied, but the most directly factor is exactly that pore stops up.After pore stopped up, the oils and fats row of hair follicle the inside did not come out, cumulatively just form one by one little small pox, and comedo comes to this and takes place.Not too serious comedo can both be seen the top of white or black usually; Here it is hoary hair's acne and blackhead, you also can extrude some white secretions, and Here it is is deposited in the oils and fats of pore the inside; Be not dirty thing, neither so-called acarid.As long as pore does not stop up, small pox just can not come up easily.Comedo and acne is a kind of dermatosis, forms general and endocrine disturbance, androgen secretion is vigorous relevant, need carry out the balance of the interior androgen of endocrine conditioning and body.
Summary of the invention
The present invention to the problem that acne is difficult to treat, is a prescription with the Chinese herbal medicine for solving deficiency of the prior art, provides a kind of property of medicine gentle, totally nontoxic, treatment short treating period, the Chinese medicine composition of eutherapeutic treatment acne.For realizing goal of the invention of the present invention, realize in the following manner: a kind of Chinese medicine composition of treating acne, its special character are that Chinese crude drug is according to following weight portion proportioning: Radix Scutellariae 10-20 part; Cortex Moutan 10-20 part, Herba Schizonepetae 5-15 part, Radix Angelicae Dahuricae 5-15 part; Radix Rehmanniae 10-20 part, Radix Platycodonis 5-15 part, Radix Sophorae Flavescentis 10-25 part; Rhizoma Smilacis Glabrae 15-25 part, Flos Chrysanthemi 10-20 part.
For better realizing goal of the invention of the present invention, the preferred version of such scheme is:
Above-mentioned said Chinese crude drug is according to following weight portion proportioning: Radix Scutellariae 13-17 part, Cortex Moutan 13-17 part, Herba Schizonepetae 8-12 part, Radix Angelicae Dahuricae 8-12 part, Radix Rehmanniae 13-17 part, Radix Platycodonis 8-12 part, Radix Sophorae Flavescentis 15-23 part, Rhizoma Smilacis Glabrae 18-23 part, Flos Chrysanthemi 13-17 part.
Above-mentioned said Chinese crude drug is according to following weight portion proportioning: 15 parts of Radix Scutellariae, 15 parts of Cortex Moutans, 10 parts of Herba Schizonepetae, 10 parts of the Radixs Angelicae Dahuricae, 15 parts in the Radix Rehmanniae, 10 parts of Radix Platycodoniss, 20 parts of Radix Sophorae Flavescentiss, 20 parts of Rhizoma Smilacis Glabraes, 15 parts of Flos Chrysanthemis.
Above-mentioned described Chinese crude drug is according to processing pill, tablet or capsule according to existing pharmaceutical manufacturing.
More than the mutual coordinative role of each component.The physical function of adjustable patient carries out the balance of androgen in endocrine conditioning and the body, and patient is got well.Therapeutic effect is remarkable, and total cure rate reaches more than 90%.The present invention provides a kind of safety non-toxic, and is easy to use, has the Chinese medicine composition of treatment acne.
Radix Scutellariae: another name Radix Scutellariae, tsuchikane tea root.For the labiate Radix Scutellariae, be used as medicine with root.Heat clearing and damp drying is arranged, and removing heat from blood is antiabortive, detoxicating functions.Cure mainly diseases such as epidemic febrile disease, upper respiratory tract infection, cough due to lung-heat, damp and hot jaundice, pneumonia, dysentery, hemoptysis, conjunctival congestion, frequent fetal movement, hypertension, carbuncle furuncle.
Cortex Moutan: antipyretic; Blood-cooling drugs.
Herba Schizonepetae: suffering, tepor.Return lung, Liver Channel.
The Radix Angelicae Dahuricae: meridian distribution of property and flavor: suffering, temperature.Attach to the lung and stomach meridians.Expelling wind and cold, understand things pain-stopping, detumescence and apocenosis, dampness leukorrhagia stopping.
The Radix Rehmanniae: Radix Rehmanniae is sweet, bitter, and is cold.GUIXIN, liver, kidney channel.
Radix Platycodonis: bitter in the mouth, suffering, slightly warm in nature.Go into lung meridian.
Radix Sophorae Flavescentis: heat clearing and damp drying, parasite killing, diuresis.Be used for hematodiarrhoea, have blood in stool, jaundice urine retention, leucorrhea with red and white discharge, swelling of the vulva pudendal pruritus, eczema, eczema, skin pruritus, scabies leprosy; External treatment trichomonal vaginitis.
Rhizoma Smilacis Glabrae: detoxifcation, dehumidifying, sharp joint. control syphilis, stranguria with turbid discharge, the muscles and bones spasm and pain, beriberi, furuncle is treated skin ulcer, carbuncle, scrofula.
Typical case's introduction of falling ill:
Clinically, acne is divided into four ranks, is respectively I, II, III, IV level.Slightly (I level) is main with acne, and a small amount of pimple and pustule are arranged, and total focus number is less than 30.Moderate (II level) has acne, and the pimple and the pustule of moderate quatity are arranged, and total focus number is between 31～50.Moderate (III level) has a large amount of pimples and pustule, and total focus number is between 51～100, and tuberosity is less than 30.Severe (IV level) is tuberosity, acne cystica or acne conglobata, and with pain and form cyst, the focus number is more than 100, and tuberosity, cyst are more than 30.Clinically, the most common with the moderate acne, be the key that promotes the acne rehabilitation to effective treatment of moderate acne.
Diagnostic criteria: distinguish that with reference to " traditional Chinese medical science disease diagnosis criterion of therapeutical effect " and Zhao " clinical dermatology " shown draft: the pubarche morbidity; Send out in face well, go up the flourishing positions of sebaceous gland such as breast and back; Be symmetrically distributed; Skin lesion is pimple, acne, pustule, tuberosity, with seborrhea, is chronic process.
The case exclusion standard: (1) once had Drug therapy acne medical history in nearly 2 weeks.(2) be associated with hypertension, diabetes, severe cardiac, lung, liver, kidney, cerebral lesion and blood system, hormonal system pathological changes person.(3) Secondary cases acne, acne conglobata, acne fulminans, occupational acne and acne necrotica patient.(4) gestation and nurture phase women.(5) spiritedness medical history patient.(6) suffer from the face dermatosis that other possibly influence laboratory observation, like lupus erythematosus, allergic dermatitis, psoriasis etc.(7) can not accomplish the patient who treats or drop by the wayside treatment on request.
Criterion of therapeutical effect: face: decrease and observe standards of grading with reference to the standards of grading in " traditional Chinese medical science disease diagnosis criterion of therapeutical effect ".
Comprehensive therapeutic effect evaluation criteria: reference " traditional Chinese medical science disease diagnosis criterion of therapeutical effect ": integration * 100% before therapeutic index=(integration after integration one is treated before the treatment)/treatment.Clinical cure: therapeutic index i＞90%; Produce effects: 70%≤therapeutic index＜90%; Effectively: 50%≤therapeutic index＜70%; Invalid: therapeutic index＜50%.
10 of acne I level sufferers mainly adopt the mode of decoction to treat, and are a course of treatment with the sky, and after 2-3 the course of treatment, acne symptom obviously weakens, and the lighter cures fully.
10 of acne II level sufferers mainly adopt the mode of tablet to treat, and are a course of treatment with the sky, and after 2-3 the course of treatment, acne symptom obviously weakens.
10 of acne III level sufferers mainly adopt the mode of pill to treat, and are a course of treatment with the sky, and after 2-3 the course of treatment, acne symptom obviously weakens.
10 of acne IV level sufferers mainly adopt the mode of drop pill to treat, and are a course of treatment with the sky, and after 3-4 the course of treatment, acne symptom obviously weakens.
The specific embodiment
Embodiment 1:
A kind of Chinese medicine composition of treating acne is characterized in that Chinese crude drug is according to following weight portion proportioning: 5 parts of Radix Isatidis, 5 parts of Radix Platycodoniss, 10 parts on Folium Mori, 25 parts of Rhizoma Imperataes, 5 parts of Herba Menthaes, 5 parts of Semen Sojae Preparatum, 10 parts of the Rhizoma Anemarrhenaes, 10 parts of Periostracum Cicadaes, 3 parts of fresh gingers.With above Chinese medicinal components mix homogeneously, put into container then and add after 1000g water boils, remove slag and pour out solution, process decoction and take.
Embodiment 2:
A kind of Chinese medicine composition of treating acne is characterized in that Chinese crude drug is according to following weight portion proportioning: 20 parts of Radix Isatidis, 20 parts of Radix Platycodoniss, 20 parts on Folium Mori, 35 parts of Rhizoma Imperataes, 10 parts of Herba Menthaes, 15 parts of Semen Sojae Preparatum, 30 parts of the Rhizoma Anemarrhenaes, 25 parts of Periostracum Cicadaes, fresh ginger 3-10 part.Above Chinese medicinal components is put into container dry, pulverize mix homogeneously and add Mel, be prepared into pill and take by the course of treatment.
Embodiment 3:
A kind of Chinese medicine composition of treating acne is characterized in that Chinese crude drug is according to following weight portion proportioning: 10 parts of Radix Isatidis, 10 parts of Radix Platycodoniss, 14 parts on Folium Mori, 28 parts of Rhizoma Imperataes, 7 parts of Herba Menthaes, 8 parts of Semen Sojae Preparatum, 15 parts of the Rhizoma Anemarrhenaes, 13 parts of Periostracum Cicadaes, 5 parts of fresh gingers.As above Chinese medicine is produced oral medicine according to the production technology of capsule dress powder.
Embodiment 4
A kind of Chinese medicine composition of treating acne is characterized in that Chinese crude drug is according to following weight portion proportioning: 15 parts of Radix Isatidis, 15 parts of Radix Platycodoniss, 18 parts on Folium Mori, 32 parts of Rhizoma Imperataes, 9 parts of Herba Menthaes, 14 parts of Semen Sojae Preparatum, 25 parts of the Rhizoma Anemarrhenaes, 18 parts of Periostracum Cicadaes, 8 parts of fresh gingers.As above Chinese medicine is produced the tablet oral medicine according to the production technology of the routine of tablet oral medicine.
Embodiment 5
A kind of Chinese medicine composition of treating acne is characterized in that Chinese crude drug is according to following weight portion proportioning: 13 parts of Radix Isatidis, 13 parts of Radix Platycodoniss, 16 parts on Folium Mori, 30 parts of Rhizoma Imperataes, 8 parts of Herba Menthaes, 12 parts of Semen Sojae Preparatum, 20 parts of the Rhizoma Anemarrhenaes, 15 parts of Periostracum Cicadaes, 6 parts of fresh gingers.As above Chinese medicine is produced capsule according to the production technology of the routine of tablet oral medicine.
Claims (4)
1. a Chinese medicine composition of treating acne is characterized in that Chinese crude drug is according to following weight portion proportioning; Radix Scutellariae 10-20 part, Cortex Moutan 10-20 part, Herba Schizonepetae 5-15 part, Radix Angelicae Dahuricae 5-15 part, Radix Rehmanniae 10-20 part, Radix Platycodonis 5-15 part, Radix Sophorae Flavescentis 10-25 part, Rhizoma Smilacis Glabrae 15-25 part, Flos Chrysanthemi 10-20 part.
2. the Chinese medicine composition of treatment acne according to claim 1 is characterized in that Chinese crude drug is according to following weight portion proportioning: Radix Scutellariae 13-17 part, Cortex Moutan 13-17 part; Herba Schizonepetae 8-12 part, Radix Angelicae Dahuricae 8-12 part, Radix Rehmanniae 13-17 part; Radix Platycodonis 8-12 part; Radix Sophorae Flavescentis 15-23 part, Rhizoma Smilacis Glabrae 18-23 part, Flos Chrysanthemi 13-17 part.
3. according to the Chinese medicine composition of claim 1 treatment acne, it is characterized in that Chinese crude drug is according to following weight portion proportioning: 15 parts of Radix Scutellariae, 15 parts of Cortex Moutans, 10 parts of Herba Schizonepetae; 10 parts of the Radixs Angelicae Dahuricae, 15 parts in the Radix Rehmanniae, 10 parts of Radix Platycodoniss; 20 parts of Radix Sophorae Flavescentiss, 20 parts of Rhizoma Smilacis Glabraes, 15 parts of Flos Chrysanthemis.
4. according to the Chinese medicine composition of claim 1 or the described treatment acne of 2 or 3 arbitrary claim, it is characterized in that processing pill, tablet or capsule according to existing pharmaceutical manufacturing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110156586 CN102805830A (en) | 2011-05-31 | 2011-05-31 | Traditional Chinese medicine composite for treating acne |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110156586 CN102805830A (en) | 2011-05-31 | 2011-05-31 | Traditional Chinese medicine composite for treating acne |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102805830A true CN102805830A (en) | 2012-12-05 |
Family
ID=47229814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110156586 Pending CN102805830A (en) | 2011-05-31 | 2011-05-31 | Traditional Chinese medicine composite for treating acne |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102805830A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103225131A (en) * | 2013-05-06 | 2013-07-31 | 渤海大学 | Al2O3, Cr2O3 composite nanofiber or nanosheet prepared from chromium-bearing aluminium sludge and preparation method thereof |
| CN103494903A (en) * | 2013-10-23 | 2014-01-08 | 张正全 | Externally-used Chinese herbal medicine agent for treating scalds and burns of skin and preparation method |
| CN104840509A (en) * | 2015-05-28 | 2015-08-19 | 李健 | Externally applied pharmaceutical composition for treating acne and application thereof |
| EP3459555A4 (en) * | 2016-05-18 | 2019-03-27 | Nippon Zettoc Co., Ltd. | Composition for oral cavity |
-
2011
- 2011-05-31 CN CN 201110156586 patent/CN102805830A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103225131A (en) * | 2013-05-06 | 2013-07-31 | 渤海大学 | Al2O3, Cr2O3 composite nanofiber or nanosheet prepared from chromium-bearing aluminium sludge and preparation method thereof |
| CN103494903A (en) * | 2013-10-23 | 2014-01-08 | 张正全 | Externally-used Chinese herbal medicine agent for treating scalds and burns of skin and preparation method |
| CN103494903B (en) * | 2013-10-23 | 2016-06-22 | 张正全 | A kind of Chinese herbal medicine for external use agent treating skin scalds and burns and preparation method |
| CN104840509A (en) * | 2015-05-28 | 2015-08-19 | 李健 | Externally applied pharmaceutical composition for treating acne and application thereof |
| EP3459555A4 (en) * | 2016-05-18 | 2019-03-27 | Nippon Zettoc Co., Ltd. | Composition for oral cavity |
| US10603271B2 (en) | 2016-05-18 | 2020-03-31 | Nippon Zettoc Co., Ltd. | Oral composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1315526C (en) | Chinese herbal medicine for treating lumbar intervertebral disk protrusion and hyperosteogeny | |
| CN104983818A (en) | Traditional Chinese medicine for treating gynecologic diseases, and preparation method thereof | |
| CN104524337A (en) | Traditional Chinese medicine for treating dental ulcer | |
| CN102526566B (en) | Chinese medicine preparation for treating hysteromyoma and ovaricyst and preparation method | |
| CN104940810A (en) | Traditional Chinese medicine composition for treating angina | |
| CN102000164A (en) | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof | |
| CN102805830A (en) | Traditional Chinese medicine composite for treating acne | |
| CN103169883B (en) | Traditional Chinese medicine for treating infantile jaundice | |
| CN103272189B (en) | Medicine for curing gallstones | |
| CN103405708B (en) | Drug for treating chronic enteritis and preparation method thereof | |
| CN103110756B (en) | Traditional Chinese medicine composition for treating renal hematuria | |
| CN105521332A (en) | Traditional Chinese medicinal composition for treating anal fissure, and preparation method and application thereof | |
| CN105343313A (en) | Traditional Chinese medicinal composition for treating senile skin pruritus and preparation method of traditional Chinese medicinal composition | |
| CN105106674A (en) | Traditional Chinese medicine composition for treating senile skin pruritus and preparation method of composition | |
| CN105267630A (en) | Traditional Chinese medicine for treating tinnitus | |
| CN103566259A (en) | Traditional Chinese medicine composition for treating skin diseases | |
| CN102836405B (en) | Medicament for treating encephaloma | |
| CN101612291B (en) | Medicine composition for treating psoriasis | |
| CN105250807A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN105169111A (en) | Traditional Chinese medicine composition for treating chronic urticaria and application of traditional Chinese medicine composition | |
| CN105125814A (en) | Traditional Chinese medicine composite for treating chronic renal failure III and IV stages | |
| CN104491690A (en) | Pharmaceutical composition for treating skin itching | |
| CN105288473A (en) | Traditional Chinese medicine composition for treating lupus erythematosus and application thereof | |
| CN105148164A (en) | Antai Buqi Chinese herbal medicament for livestock | |
| CN104208510A (en) | Medicine for treating chronic nephritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20121205 |